1. Boppana, S.B. and Britt, W.J. 2013. Synopsis of clinical aspects of human cytomegalovirus disease. In Reddehasse, M.J. (ed.), Cytomegaloviruses: from molecular pathogenesis to intervention. vol. 2, pp. 1–25. Caister Academic Press, Norfolk, United Kingdom.
2. Bos, K., Wraight, C., and Stanley, K.K. 1993. TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain. EMBO J.12, 2219–2228.
3. Britt, W. 2007. Virus entry into host, establishment of infection, spread in host, mechanisms of tissue damage. In Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., and Yamanishi, K. (eds.), Human herpesviruses: biology, therapy, and immunoprophylaxis, chapter 41. Cambridge University Press, Cambrige, England.
4. Britt, W.J. 2010. Cytomegalovirus. In Remington, J.S., Klein, J.O., Wilson, C.B., Nizet, V., and Maldonaldo, Y. (eds.), Infectious diseases of the fetus and newborn infant. 7th edn. pp. 706–755. Saunders, Philadelphia, Pennsylvania, USA.
5. Britt, W.J. and Auger, D. 1986. Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. J. Virol.58, 185–191.